Advertisement

Topics

Companies Related to "Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma" [Most Relevant Company Matches] - Page: 5 RSS

02:06 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma" found in our extensive corporate database of over 50,000 company records.

Showing "Study Cucumber Extract Patients With Untreated Asymptomatic Myeloma" Companies 101–125 of 4,300+

Probably Relevant

Oncimmune LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...


Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enl...


Clinical Network Services (CNS)

Clinical Network Services (CNS) Pty Ltd is an Australian CRO, focused on providing full contract research organisational clinical trial services to the international healthcare community particularly during the early phase (Phase I and Phase II) clinical development of their products. CNS has established itself as Brisbane’s only headquartered Australian CRO working both nationally with dedicat...

ClinicalStudyResults.org

The ClinicalStudyResults.org site is a central, widely accessible, web-based repository for clinical study results in a reader-friendly, standardized format. This database will serve the valuable function of making clinical trial results for for many marketed pharmaceuticals more transparent. More importantly, it is designed as a key tool to provide information to practicing physicians and their p...

RecordAF registry

The RecordAF survey recruited 5,604 patients with recent onset atrial fibrillation from 21 countries spanning North and South America, Europe and Asia (5,171 patients - 92.3 percent were evaluable after 12-month follow-up). They were followed-up for a period of one year. The primary outcomes of the study were therapeutic success and clinical outcomes associated with rhythm- and rate-control st...

ideallianceinc

The Idealliance was originally formed as the North Carolina Emerging Technology Alliance (NCETA) in 1998. This organization of academic, business and government leaders was created in response to recommendations put forth in a study commissioned by the Greater Winston-Salem Chamber of Commerce. This study, entitled Forsyth County’s Blueprint for Technology Development, was part of a community-wi...

PLC Systems Inc.

PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney...

invivodata, inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases ...

Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

OI Analytical

O.I.Corporation, dba OI Analytical, provides innovative products used for chemical analysis. We develop, manufacture, sell, and service analytical instruments that detect, measure, analyze, and monitor chemicals in liquids, solids, and gases. We also provide products used to digest, extract, and separate components of chemical mixtures

ProFibrix B.V.

Fibrocaps is based on a mixture of two essential blood clotting proteins, fibrinogen and thrombin, and is a unique dry powder topical tissue sealant in development to stop bleeding after or during surgery. Fibrocaps is clearly differentiated from existing liquid tissue sealants and hemostats: it is ready for immediate use, is stable at room temperature, and has shown to be safe and efficacious...

Trevigen Incorporated

Trevigen is a long standing provider of quality kits and reagents for researchers investigating programmed cell death, DNA damage and repair, cell differentiation and angiogenesis. Trevigen recently launched PathClear™ Basement Membrane Extract in the Cultrex® product line." Telephone Toll Free: 1-800-TREVIGEN

Valentis

Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announced that no statistically significant difference was seen in the primary endpoint or any of the secondary endpoints in its Phase IIb clinical trial of VLTS 934 in PAD. The primary efficacy endpoint in t...

Tax Point Advisors

Tax Point Advisors (sm), the nation’s premier provider of research and development tax credit studies, comprises a trusted team of former Big4 accountants, business advisers, and staff with extensive industrial/manufacturing/technical industry background providing the highest degree of professional service. We assist CPA’s and their clients in identifying and capturing their maxim...

Max-Planck-Institut für Plasmaphysik

Max-Planck-Institut für Plasmaphysik (IPP) at Garching and Greifswald provides training for young scientists, ranging from temporary assignments for undergraduates and practicals for students on completion of their intermediate diploma, through the allocation and supervision of diploma and PhD theses, to the presentation of comprehensive courses of graduate study with seminars, colloquia and stud...

AEterna Laboratories Incorporated

Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal trials for the treatment of lung and kidney cancer, and multiple myeloma, a type of blood cancer.

The Patients Association

The Patients Association is a registered charity, staffed by paid and unpaid staff. The Patients Association offers patients an opportunity to share their experiences of health services. The Patients Association uses the knowledge it gains from patients to work with the NHS and other healthcare providers to improve services. The Patients Association works with a range of organisations providing he...

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is ag...

HearUSA, Inc.

HearUSA, Inc. (NYSE Amex: EAR) is the recognized leader in hearing care for the nation’s top managed care organizations through its network of more than 1,800 hearing care provider locations, including 134 company-owned centers. HearUSA is the nation’s only hearing care network accredited by URAC, an independent, nonprofit health care accrediting ...

Cyberonics Incorporated

Cyberonics, Inc. (NASDAQ: CYBX) pioneered the Vagus Nerve Stimulation (VNS Therapy™) System. Founded in 1987 to design, develop and market implantable medical devices for the treatment of epilepsy and other debilitating neurological disorders, Cyberonics has emerged as a leader in the neuromodulation industry. The VNS Therapy System uses a surgically implanted medical device that delivers elec...

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...

Dendreon Corporation

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates de...

Semasopht

Semasopht provides a cutting-edge image analysis software for 2D and 3D particle tracking. Our innovative methods allow to reliably follow thousands of objects simultaneously at a precision below 0.001 pixels. DiaTrack 3.0 is fully stand-alone and provides a compelling set of tools to extract quantitative information from image sequences, for a wide array of applications. View a streaming demo or ...


More From BioPortfolio on "Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks